Corvidia Therapeutics has a total of 27 patents globally, out of which no patents have been granted. Of these 27 patents, more than 66% patents are active. Israel is where Corvidia Therapeutics has filed the maximum number of patents, followed by Korea (South) and Hong Kong (S.A.R.). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Corvidia Therapeutics.
Corvidia Therapeutics was founded in the year 2014. The Company discovers, develops and commercializes precision therapeutics for the treatment of diseases.
Do read about some of the most popular patents of Corvidia Therapeutics which have been covered by us in this article and also you can find Corvidia Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Corvidia Therapeutics patent portfolio.
How many patents does Corvidia Therapeutics have?
Corvidia Therapeutics has a total of 27 patents globally. These patents belong to 5 unique patent families. Out of 27 patents, 18 patents are active.
How Many Patents did Corvidia Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Corvidia Therapeutics Applications Filed | Corvidia Therapeutics Patents Granted |
2021 | 1 | – |
2020 | 7 | – |
2019 | 9 | – |
2018 | 10 | – |
How many Corvidia Therapeutics patents are Alive/Dead?
How Many Patents did Corvidia Therapeutics File in Different Countries?
Countries in which Corvidia Therapeutics Filed Patents
Country | Patents |
Israel | 4 |
Korea (South) | 3 |
Hong Kong (S.A.R.) | 3 |
India | 3 |
Taiwan | 2 |
Brazil | 2 |
Japan | 2 |
Viet Nam | 1 |
Colombia | 1 |
Chile | 1 |
Malaysia | 1 |
Where are Research Centres of Corvidia Therapeutics Patents Located?
List of Corvidia Therapeutics Patents
Corvidia Therapeutics Patents | Title |
HK40031127A | Methods For Treating Il-6 Mediated Inflammation Without Immunosuppression |
HK40019119A | Treatment Of Diuretic Resistance |
HK40017993A | Apoc-Ii Mimetic Peptides |
IL281274A | Treatment Of Diuretic Resistance |
IL279831A | Apoc-Ii Mimetic Peptides |
IL275696A | Methods For Treating Il-6 Mediated Inflammation Without Immunosuppression |
IL268093A | Apoc-Ii Mimetic Peptides |
TW202130366A | Precision Treatment Of Heart Failure And Cardiorenal Syndrome |
CL202001790A1 | Methods To Treat Il-6 Mediated Inflammation Without Immunosuppression |
BR112020013519A2 | Method For Treatment Of Inflammation. |
VN74290A | Il-6 Antagonists For The Treatment Of Il-6-Mediated Inflammation Without Immune Suppression |
CO20200009510A2 | Methods To Treat Il-6 Mediated Inflammation Without Immunosuppression |
BR112019014707A2 | Isolated Apoc-Ii Mimetic Peptide, Pharmaceutical Composition, And, Methods For Treatment Hypertriglyceridemia And For Manufacturing The Peptide. |
KR1020200012823A | Treatment Of Diuretic Resistance |
IN201917034989A | Treatment Of Diuretic Resistance |
KR1020190121305A | Apoc-Ii Mimetic Peptides |
IN201917032726A | Apoc-Ii Mimetic Peptides |
MYPI2020003508A0 | Methods For Treating Il-6 Mediated Inflammation Without Immunosuppression |
WO2020223565A1 | Anti-Il-6 Antibody Formulation |
WO2018136803A8 | Apoc-Ii Mimetic Peptides |
WO2019136312A1 | Methods For Treating Il-6 Mediated Inflammation Without Immunosuppression |
WO2018144773A1 | Treatment Of Diuretic Resistance |
JP2020506190A5 | Treatment Of Diuretic Resistance |
JP2021509668A | Methods Of Treating Il-6-Mediated Inflammation Without Immunosuppression |
TW202130652A | Apoc-Ii Mimetic Peptides |
KR1020200116089A | Methods For Treating Il-6-Mediated Inflammation Without Immunosuppression |
IN202017031759A | Methods For Treating Il-6 Mediated Inflammation Without Immunosuppression |
What are Corvidia Therapeutics key innovation segments?
What Technologies are Covered by Corvidia Therapeutics?
The chart below distributes patents filed by Corvidia Therapeutics